Form 8-K - Current report:
SEC Accession No. 0001193125-23-016245
Filing Date
2023-01-26
Accepted
2023-01-26 16:16:00
Documents
13
Period of Report
2023-01-26
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d642303d8k.htm   iXBRL 8-K 25737
2 EX-99.1 d642303dex991.htm EX-99.1 10878
  Complete submission text file 0001193125-23-016245.txt   166361

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sana-20230126.xsd EX-101.SCH 2829
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sana-20230126_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sana-20230126_pre.xml EX-101.PRE 11693
7 EXTRACTED XBRL INSTANCE DOCUMENT d642303d8k_htm.xml XML 3473
Mailing Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102
Business Address 188 EAST BLAINE STREET, SUITE 400 SEATTLE WA 98102 (206) 701-7914
Sana Biotechnology, Inc. (Filer) CIK: 0001770121 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39941 | Film No.: 23557909
SIC: 2836 Biological Products, (No Diagnostic Substances)